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Introduction: Observational studies consistently support strate-
gies for early cancer diagnosis and treatment. Owing to its high 
prevalence, mortality rate, and easily identiﬁable at-risk population 
groups, lung cancer seems ideal for early detection programs. We 
present the baseline results of the SOS study, a single-arm observa-
tional study of digital chest tomosynthesis for lung cancer detection 
in an at-risk population.
Methods: Accrual of study participants started in December 2010 
and ended in December 2011. Participants considered eligible were 
smokers or former smokers aged 45 to 75 years, with a smoking 
history of at least 20 pack-years, without malignancy in the 5 years 
before the start of the study. A tomosynthesis examination was per-
formed at baseline and another the year after.
Results: Of the 1919 candidates assessed, 1843 (96%) were enrolled 
into the study: the mean age was 61 years (range, 48–73 years); 1419 
(77%) were current smokers. The most prevalent comorbidities were 
hypertension, chronic obstructive pulmonary disease, and cardiovas-
cular diseases. A total of 1843 tomosynthesis studies were obtained. 
Pulmonary abnormalities were detected in 268 subjects (14.5%). First-
line basal computed tomography (CT) was subsequently carried out in 
132 subjects (7.2%), 68 (4.9%) of which were referred for follow-up 
CT. Positron-emission tomography/CT was performed on 27 individu-
als (1.46%), and lung cancer was detected in 18 (0.98%) of them.
Conclusion: The detection rate of noncalcified lung nodules for tomo-
synthesis was comparable with rates reported for CT. A small subgroup 
underwent low-dosage CT and entered a follow-up program. Overall, 
lung cancer was detected in approximately 1% of cases. Digital chest 
tomosynthesis holds promise as a first-line lung cancer screening tool.
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Lung cancer is the leading cause of cancer-related deaths in the United States and most of the western and devel-
oping countries. Most lung cancers are detected when 
patients become symptomatic and have late-stage disease. 
However, recently, computed tomography (CT) screening 
for lung cancer has been reported to reduce lung cancer 
mortality.1 In this regard, the National Lung Screening Trial 
(NLST)1 showed a 20% reduction in lung cancer-specific 
deaths in those patients who had screening performed with 
chest CT. However, CT is associated with the disadvantages 
of high radiation dosage and cost. Digital chest tomosyn-
thesis (DT), a tomographic technique, may offer an alterna-
tive to CT screening. DT uses a conventional radiograph 
tube, a flat-panel detector, a computer-controlled tube 
mover, and special reconstruction algorithms to produce 
section images. Compared with conventional chest radi-
ography, chest tomosynthesis improved sensitivity in the 
detection of CT-proven lung nodules. DT is able to detect 
most lung nodules larger than 5 mm, in particular 91% of 
nodules, whose sizes were between 4 mm and 6 mm, and 
100% of nodules larger than 6 mm, detected in a CT scan.2,3 
In addition, the effective radiation dosage to patients from 
chest examination with DT is low (approximately 0.13 mSv 
compared with 0.1 mSv for a postero-anterior and lateral 
chest radiograph).4 Although it lacks the depth resolution 
of CT, tomosynthesis provides some of the benefits of CT 
at lower costs and radiation dosages. Furthermore, DT is 
less expensive than CT at approximately one-sixths of the 
cost of a CT.5
In this single-arm observational study (SOS Study), DT 
was used for early detection of lung cancer. The study was 
approved by the Institutional Ethics Committee (approval no. 
68/09). We report the results of the 1-year baseline DT in a 
population at risk of having lung cancer.
MATERIALS AND METHODS
Study Design
A sample size of 2000 subjects was planned, which 
was calculated on the basis of incidence and mortality data 
extracted from the Piedmont Cancer Registry.6 Subject recruit-
ment was through general practitioners, advertising leaflets, 
and the local media. Inclusion criteria were: current or former 
smoker status; smoking history of at least 20 pack-years; age 
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45 to 75 years; no history of cancer in the 5 years before the 
start of the study; and no chest CT study in the 12 months up 
to enrolment. For former smokers, the maximum time since 
quitting smoking was 10 years. Candidates were assessed 
for eligibility by telephone interview with the project assis-
tant (Fig. 1). Written informed consent was obtained before 
entry into the study, in accordance with the requirements of 
the institutional review board and local health authorities, and 
a questionnaire was administered, investigating occupational 
history, smoking habits, and past and present health condi-
tions. An additional inclusion criterion specific for image 
acquisition was that subjects be able to stand and hold their 
breath for 11 seconds.
Digital Chest Tomosynthesis
Under the study protocol, a tomosynthesis examination 
was performed at baseline in all subjects and another a 
year later in those with a negative baseline scan. In all, 
one baseline and a first-round examination were planned. 
All subjects were informed about their examination results 
by letter. Scans were obtained on a commercially available 
system (Volume RAD; GE Healthcare, Chalfont St Giles, 
England) consisting of an radiograph tube, a wall stand, a 
stationary antiscattered grid (70 lines per cm; ratio 13:1), 
and a cesium iodide amorphous silicon (Csl/a-Si) flat-panel 
detector system (41 × 41 cm2; 200 × 200 mm2 pixel size). 
A mean of 60 projection images were acquired along a 
vertical path of 60° of total tube angular motion (Fig. 2). A 
FIGURE 1.  Telephone questionnaire—
eligibility criteria.
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set of images were acquired in 10 to 12 seconds of breath-
hold condition, which these asymptomatic subjects easily 
achieved. The images were then reconstructed in 3-mm 
plane spacing in the coronal plane. Image reconstruction was 
done using the matrix inversion tomosynthesis algorithm 
(simultaneous algebraic reconstruction technique), and 
a sliding average of seven adjacent planes was selected to 
reduce noise and low-contrast tomosynthesis artifacts. The 
mAs in roentgenogram were set with an automated control 
of the exposure to be 10 times lower than the ones used for 
the chest radiograph. A scout image (chest radiograph) was 
obtained to check patient position; if satisfactory, the system 
then calculated the appropriate low-dosage exposure (mAs) 
for the tomosynthesis scan. The acquisition data are reported 
in Table 1. The images fully covered the field from the anterior 
skin to the back of the chest.
Interpretation of Tomosynthesis Images
Two radiologists independently viewed the tomosyn-
thesis images. One had more than 20 years of experience 
with chest imaging and 1 year of clinical experience with 
tomosynthesis. The other has 5 years of experience with 
chest imaging and a few months of clinical experience with 
tomosynthesis. Both observers were instructed to mark the 
lung nodules on the tomosynthesis images. Each nodule was 
marked on only one image per imaging technique and in 
the most prominent location. The observers were allowed to 
change window width and level and image contrast, and use 
the pan and zoom functions. All readings were performed on 
a picture archiving and communications system-integrated 
workstation. The largest diameter in the transverse plane 
was measured. Lung nodules or opacities were classified as 
definitely benign (completely calcified or with a calcification 
pattern typical of benign disease) or uncertain (possible lung 
cancer nodule).
Interpretation and Workup of Suspicious 
Pulmonary Abnormalities
For subjects with a benign nodule or a nodule 5 mm 
or less in size, a second tomosynthesis study was performed 
a year later. Subjects, with an uncertain nodule larger than 
5 mm or with multiple nodules were defined as positive 
and underwent low-dosage CT or contrast-enhanced CT, 
depending on the nodule size, and in keeping with the 
Fleischner Society guidelines for the management of small 
pulmonary nodules.7 Diagnostic CT was performed on a 
FIGURE 2.  Digital chest 
tomosynthesis.
TABLE 1.  Acquisition Parameters of Digital Chest 
Tomosynthesis and Chest CT Images
Images and Parameters
Digital chest tomosynthesis
 Voltage 120 kV
 Detector entrance dosage 0.5 μGy
 Nominal focal spot 0.6 mm
 Additional copper filtration 0.1 mm
 AEC speed 400
 Average 300 mAs
 Dosage ratio 1:10
 Total exposition time 11.4
 Mean number of images 94
 Rotation angle 30°
 Gap 3 mm
Chest CT
 Voltage 120 kV
 Total exposition time 0.4
 Average 250 mAs
 Pitch 1.5
CT, computed tomography; AEC, automatic exposure control.
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Brilliance 64 scanner (Philips, Eindhoven, The Netherlands). 
A helicoidal CT scan was acquired, with 120 kV, 300 mAs, 
rotation time 0.42 seconds, pitch 1.5, and 5-mm slice thickness. 
CT was performed in accordance with the Fleischner Society 
guidelines.7 If the CT scan confirmed a nodule less than 
10 mm and showed nonsuspicious characteristics, it was 
defined as possibly benign, and the subject was asked to 
return for follow-up CT at 3 or 6 months, and then again at 12 
months. If the CT scan confirmed a nodule larger than 8 mm 
with not definitely benign features, invasive diagnostic testing 
was considered and positron-emission tomography (PET) 
was performed. If the PET scan was positive, tissue diagnosis 
was obtained by bronchoscopy, percutaneous fine-needle 
aspiration biopsy, or video-assisted thorascopic surgery or 
thoracotomy. If the PET scan was negative, close follow-up was 
preferentially chosen and biopsy recommended, if the nodule 
had meanwhile grown in size (Fig. 3). Subjects noted to have 
mediastinal enlargement, pleural effusion or tumor, or lytic 
bone lesions were referred for further diagnostic testing (CT, 
thoracoscopy, bronchoscopy, or biopsy according to internal 
hospital guidelines). All uncertain cases were reviewed by 
an interdisciplinary team, including the radiologist, thoracic 
surgeon, and pneumologist. The primary endpoints were, 
detection rate of lung nodules by tomosynthesis compared 
with postero-anterior chest radiography (the scout image), the 
prevalence of lung cancer in this at-risk population, and tumor 
stage distribution.
Statistical Analysis
Raw data and proportions were compared using the 
χ2 test or Fisher’s exact test; mean values were compared 
with the t test using Satterthwaite approximation in case of 
heteroskedasticity. McNemar’s test was applied to assess 
improved observer performance in correctly diagnosing pul-
monary nodules. The weighted k statistic was calculated to 
assess interobserver agreement. Significant differences were 
defined as p values less than 0.05. Statistical analysis was car-
ried out using Mathematica 8.0 (Wolfram Research).
RESULTS
Accrual started in December 2010 and closed in January 
2011. A total of 1919 candidates underwent baseline clinical 
assessment and 76 of them were considered ineligible. The 
two most common reasons for noneligibility were, history of 
cancer and insufficient exposure to cigarette smoking. The 
mean age was 61 years (95% confidence interval, 48–73); on 
average, they smoked 580 cigarettes yearly during their life 
(95% confidence interval, 420–1400); 29% of the subjects 
were smokers at the time of accrual. Comorbidities are listed 
in Table 2.
FIGURE 3.  Early detection with 
tomosynthesis: patient management 
protocol. CT, computed tomography; 
PET-CT, positron-emission tomogra-
phy computed tomography; FVP, .
TABLE 2.  Comorbidities
Comorbidities No. (%)
 Asbestosis 2 (0.1)
 Chronic obstructive pulmonary disease 242 (12.7)
 Tuberculosis 31 (1.6)
 Pleuritis 70 (3.7)
 Previous pneumothorax 35 (1.8)
 Asthma 89 (4.7)
 Cardiopathy 201 (10.5)
 Goiter 183 (9.6)
 Previous neoplasm 117 (6.1)
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Overall, 268 subjects (14.8%) had abnormIal findings 
at the baseline tomosynthesis examination. The number 
of nodules found in each patient varied from 1 to 12. The 
detection rate with tomosynthesis for all nodules was 18.4%; 
7.2% of pulmonary nodules were indeterminate and larger 
than 5 mm. Low-dosage CT was subsequently performed in 
132 subjects (7.2%): 39 were false-positives (extrathoracic 
nodules, pleural plaques) and 93 had one or more than one 
lung nodules larger than 5 mm in size. A comparison between 
the tomosynthesis and CT scans showed that the average 
difference in nodule diameter was 0.085 ± 1.820 mm. The 
nodules were grouped by diameter into three classes (Table 3). 
Among the subjects who underwent low-dosage CT after 
tomosynthesis, the nodule detection rate with tomosynthesis 
was statistically significant (p = 0.0306), and higher than 
with the scout chest radiograph for all three nodule groups, 
and total number of nodules detected; however, there was no 
statistically significant difference (p = 0.9521) between the 
nodule detection rate with tomosynthesis compared with CT. 
A PET/CT study was obtained in 27 (1.5%) and a follow-up 
CT done on 68 subjects (3.7%), respectively.
Video-assisted thorascopic surgery for indeterminate 
pulmonary nodules other than lung cancer was performed in 
six subjects (tuberculosis nodule [n = 1], mucosa-associated 
lymphoid tissue nodule [n = 1], hamartochondroma [n = 3], 
and an intrapulmonary lymph node [n = 1] which had increased 
in size at follow-up CT) and no complications developed.
Tomosynthesis examination led to the discovery of: extra-
pulmonary tumor (lymphoma [n = 1]); interstitial lung disease 
(n = 2); severe upper-lobe bullous emphysema (Fig. 4); and non-
pulmonary pathological findings in 13 other patients (pleural 
effusion [n = 4]; pleural lesions [n = 5]; mediastinal enlargement 
[n = 4]). There were no interobserver differences regarding the 
sensitivity to detect benign lesions (p > 0.15 for benign nodules; 
McNemar test). One patient with abnormal findings on baseline 
CT and CT/PET refused further diagnostic testing.
Overall, the lung cancer prevalence was 97.67 out of 
10,000 (18/1843). Table 4 reports tumor stage and histology. 
Adenocarcinoma was the most frequent histological type: 
clinical stage IA in six cases (Figs. 5 and 6); IB in two; IIA in 
two; IIB in one; IIIA and IIIB in one case each; and IV in five. 
Surgery for lung cancer was performed in 12 of 18 subjects 
(66.6%) (lobectomy [n = 11] and pneumonectomy [n = 1]); 
six subjects received chemotherapy and/or radiotherapy for 
inoperable disease.
DISCUSSION
After the release of the NLST results, regular annual 
low-dosage CT has been strongly recommended for the target 
TABLE 3.  Number of Lung Nodules Detected with 
Tomosynthesis, Chest Radiography and Chest CT
Lung Nodules
Digital 
Tomosynthesis 
– No. (%)
Chest 
Radiography 
– No. (%)
Chest  
CT – No. 
(%)
5–8 mm 53 (91.4) 11 (19.0) 58 (100)
8–10 mm 40 (97.6) 15 (36.6) 41 (100)
>10 mm 33 (100) 21 (63.6) 33 (100)
Total 126 (95.45) 47 (35.6) 132 (100)
Values in parentheses are the difference in percentage as compared against chest 
CT; a significant difference emerged between the detection rate for tomosynthesis 
versus chest radiography (p = 0.0306) but not for tomosynthesis versus low-dosage CT 
(p = 0.9521). Statistical significance was set at p < 0.05.
CT, computed tomography.
FIGURE 4.  Digital chest tomosyn-
thesis image (B) showing severe lung 
emphysema in a smoker, which was 
barely visible on the chest radiograph 
(A). C, Chest computed tomography 
scan confirmed the tomosynthesis 
findings (D).
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group of heavy smokers (30 pack-years; 55–74 years of age) 
by the American Association for Thoracic Surgery.8 General 
public opinion widely supports cancer screening: 87% of 
interviewees believed that it is almost always a good idea; 75% 
were sure that it saved lives most or all the time; a substantial 
proportion believed that an 80-year-old person choosing not 
to be screened was irresponsible.9 Nonetheless, the adsorbed 
radiation dosages and costs associated with low-dosage CT 
screening encourage the search for other strategies for the 
early detection of lung cancer, or to select among individuals 
at high risk, those who should be referred for low-dosage CT.
The risk of developing a new cancer because of radia-
tion exposure should not be underestimated. Chest CT screen-
ing can be accomplished at an average effective dosage of 2 
mSv, and the mean effective dosage in the NLST was 1.4 ± 0.5 
mSv. But low-dosage CT must be repeated over a period of 
several years and twice a year in some cases. The estimated 
radiation dosage that each NLST participant received was 
approximately 8 mSv.10 The estimated annual average effective 
dosage equivalent that people receive from natural sources is 
more than 3 mSv.11 Moreover, flight passengers are exposed 
to radiation during supersonic flight. During a 10-hour flight 
at 60,000 to 70,000 feet, for example, a passenger receives a 
dosage equivalent as high as 0.27 mSv, with frequent flyers 
easily accumulating multiple radiation dosages.12
By contrast, the natural radiation dosage in a low-dosage 
CT screening program exposes a person to approximately 20 
TABLE 4.  Tumor Stage and Histology in Subjects with Lung 
Cancer Diagnosed by Tomosynthesis
Tumor stage No. of subjects
 IA 6
 IB 2
 IIA 2
 IIB 1
 IIIA 1
 IIIB 1
 IV 5
Histology No. of subjects
 Adenocarcinoma 10
 Squamous cell carcinoma 7
 Carcinoid 1
FIGURE 5.  Digital chest tomo-
synthesis image showing a solid 
pulmonary nodule in a 63-year-old 
man. A, The pulmonary nodule is not 
visible on the postero-anterior chest 
radiograph. B, tomosynthesis planes 
showing solid nodular opacity (white 
arrow) in the left upper lung, with 
peripheral spiculations that revealed 
a pulmonary location. C, computed 
tomography image (lung window, 
transverse plane) confirming the 
nodule, with a similar extension as 
shown by tomosynthesis.
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mSv, if other radionuclide investigations are performed in 
the meanwhile (e.g., nuclear cardiac imaging, PET/CT), or 
the person is not a frequent flyer. The cumulative radiation 
dosage can thus, rise to levels that pose an individual at risk 
of developing a second malignancy. According to the NLST 
report, data models predict that approximately one cancer death 
may be caused by radiation from imaging, per 2500 persons 
screened. The cancer incidence (International Commission on 
Radiation Protection publication recommendations stochastic 
risk coefficient) is one of 3710 for a single low-dosage CT 
study, whereas the mean effective dosage for tomosynthesis 
is approximately 0.13 mSv (International Commission on 
Radiation Protection stochastic risk coefficient 1 of 75,757).
The NLST, the most expensive randomized trial of a 
single cancer-screening test ever undertaken in the history of 
U.S. medicine, cost $200 million.1 The cost for a low-dosage 
CT examination in lung cancer screening is approximately 
$300, whereas a mammogram costs from 80 to $150. Critics 
of lung cancer screening with low-dosage CT have pointed 
to the limitations inherent to health cost analyses based on 
simulation modeling.13 Clarification expected from the NLST 
cost-effectiveness evaluation may help to settle some of the 
controversy surrounding low-dosage CT screening. Added 
to these concerns are the impact of lung cancer screening on 
medical resource allocation (cost of low-dosage CT screening 
and additional testing). For each low-dosage CT screen for 
lung cancer, Medicare (the United States health insurance pro-
gram for the elderly and disabled) reimburses approximately 
$300. With the number of high-risk individuals eligible for 
lung cancer screening currently at nearly seven million (based 
on NLST data), the annual cost in the United States alone 
would total approximately $2.1 billion.
Limiting screening to high-risk patients could elimi-
nate unnecessary procedures in individuals with a lower risk 
of cancer and keep a screening program more cost-effective. 
For example, prescreening based on age, smoking history, 
personal and family medical history, and occupational history 
would be one way to identify high-risk population subsets. 
Other factors, including the screening interval, will come into 
the cost calculation. Because low-dosage CT imaging is more 
expensive than many other screening modalities, validating 
its effectiveness is certainly warranted. As a potential alterna-
tive, DT has been shown to be superior to chest radiography 
in the detection of pulmonary nodules14,15: it detected 91% of 
nodules between 4 mm and 6 mm, and 100% of nodules larger 
than 6 mm found by CT. Recently,16 tomosynthesis was com-
pared versus CT in its ability to detect artificial pulmonary 
nodules 5 and 8 mm in diameter and ground glass opacities 
in a phantom. The detectability indices for tomosynthesis and 
CT were similar.
In our observational study involving nearly 2000 
subjects, the percentage of lung nodules and lung cancer 
FIGURE 6.  Digital chest tomosyn-
thesis image showing a solid pulmo-
nary nodule in a 47-year-old woman. 
A, The pulmonary nodule is not 
visible on the postero-anterior chest 
radiograph. B, tomosynthesis planes 
showing solid nodular opacity (white 
arrow) in the left lower lung, with 
peripheral spiculations that revealed 
a pulmonary location. C, computed 
tomography image (lung window, 
transverse plane) confirming the 
nodule in the left lower lobe.
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detected with tomosynthesis was comparable to that 
reported for low-dosage CT. The lung cancer detection rate 
was 0.9% (early stage disease in 10 of 18 subjects [55%] and 
inoperable stage IV disease in five of 18 subjects [27%]). 
By restricting the age range to 55 to 79 years, and raising 
the number of pack-years to 30, as in the NLST, an even 
higher incidence of lung cancer might have been detected. 
Admittedly, many of the health risks of screening will 
remain also with a wider use of tomosynthesis for cancer 
screening, as the NLST reported. Such risks will need to be 
balanced against the greater reduction in radiation exposure 
and screening costs.
CONCLUSION
The baseline results on the use of DT in the early detec-
tion of lung cancer are encouraging; the detection rate is com-
parable to the rates reported for low-dosage CT and is attained 
at a far lower cost and radiation dosage. The first-round tomo-
synthesis screen will provide further data about its effective-
ness in the follow-up of high-risk subjects. Experimental 
studies support the use of tomosynthesis to select those suit-
able for CT among high-risk people. Studies on a larger num-
ber of subjects are needed to confirm these results.
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